Any strategic partner that comes on board (which is pivotal to unlocking the value in the product) would only be willing to do so when their is a de-risking of the product. Results of successful clinical trials would illustrate a significant milestone is the aforementioned de-risking.
Therefore, where are the announcements to the market?
I feel like i'm missing a step here, does anyone else feel the same?
ALT Price at posting:
0.5¢ Sentiment: Hold Disclosure: Held
